• No results found

2014 CPT Code Updates

N/A
N/A
Protected

Academic year: 2021

Share "2014 CPT Code Updates"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

(1)

Page

1

of

7

2014 CPT Code Updates

This publication is a summary of The American Medical Association Current Procedural

Terminology (CPT) codes published in ARUP's Laboratory Test Directory effective January 1, 201

4

.

Tests not listed in this summary do not have CPT code changes at this time.

The American Medical Association Current Procedural Terminology (CPT) codes published in

ARUP’s Laboratory Test Directory are provided for informational purposes only. The codes reflect

our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT

codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that

clients confirm CPT codes with their Medicare Administrative Contractor (MAC), as requirements

may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no

responsibility for billing errors due to reliance on the CPT codes published.

Please direct any questions regarding CPT coding to the payer being billed.

Test Number

Test Name

2014 CPT Code(s)

0040113 PAX-FKHR Translocation by RT-PCR 81401 x2

0040114 SYT-SSX, t(X;18) Transloc by RT-PCR 81401 x2

0040137 KIT (D816V) Mutation by PCR 81402

0040168 JAK2 Gene, V617F Mutation, Quantitative 81270

0040174 NPM1 Mutation, PCR-Fragment Analysis 81310

0040203 Chorionic Villus, FISH 88271 x5; 88275 x5; 88291

0040227 IGHV Mutation Analysis by Sequencing 81263

0040248 KRAS Mutation Detection 88381; 81275; 81403

0049390 ERBB2 (HER2/neu) Amplification by PCR 88381; 81479

0050157 Hypersensitivity Pneumo Extended Panel 86003 x3; 86005; 86331 x7; 86606 x5 0050444 RUNX1-RUNX1T1 (AML1-ETO) t(8;21) RT-PCR 81401

0050446 MLL-AFF1 (MLL-AF4) t(4;11) RT-PCR 81401

0050543 Fragile X (FMR1) Diagnostic, Fetal 81243;81244; 81265

0051067 HLA DRB3, 4, 5 81382

0051220 EWS-FLI1 Translocations by RT-PCR 81401

0051245 JAK2 Gene, V617F Mutation, Qualitative 81270

0051262 Ewing's Sarcoma ERG Transloc by RT-PCR 81401

0051348 HHT, Deletion and Duplication 81405 (ENG)

81479

0051381 HHT, Sequencing 81406 (ENG)

81479 0051382 HHT, Sequencing and Deletion/Duplication 81406 (ENG)

81405 (ENG)

(2)

Page

2

of

7

0051510 Juvenile Polyposis (SMAD4) Sequencing 81406

0051682 PCD (SLC22A5) Sequencing 81405

0051740 Microsatellite Instability by PCR 88381; 81301

0051750 BRAF with Reflex to MLH1 Methylation 88381; 81210; If reflexed, add 81479

0051755 Molar Pregnancy, 16 DNA Markers 81265; 88381

0051786 Alport Syndrome (COL4A5) Sequencing 81408

0051830 Allergen, Indoor 86003 x6; 86005

0055037 Allergen, Animal, Feather Mix 86005

0055114 Allergen, Inhalant/Food, Pro 1 86003 x28; 86005

0055120 Allergen, Animal, Dander, Feather 86003 x4; 86005

0055129 Allergen, Inhalant/Food, Western 86003 x23; 86005

0055305 Allergen, Inhalant, Environment Pro 10 86003 x9; 86005

0055307 Allergen, Inhalant/Food, Environment Pro 86003 x16; 86005

0055346 TCF3-PBX1 (E2A-PBX1) t(1;19) RT-PCR 81401

0055368 Allergen, Inhalant, Multiallergen Qual 86005

0055553 BCR-ABL1, t(9;22) Qual by RT-PCR 81206; 81207

0055557 IGH-CCND1 (BCL-1/JH) t(11;14) PCR 81401

0055567 T-Cell Clonality Screening by PCR 81342

0055616 IGH-BCL2 (BCL-2/JH) t(14;18) PCR 81402

0055691 BIRC2-MALT1(API2-MALT1) t(11;18) RT-PCR 81479

0056008 ETV6-RUNX1 (TEL-AML1) t(12;21) RT-PCR 81401

0060110 Culture, Neisseria gonorrhoeae 87081; Identification CPT codes may vary based on method

0060113 Culture, Legionella species 87081; Identification CPT codes may vary based on method

0060117 Culture, Bordetella pertussis 87081; Identification CPT codes may vary based on method

0060124 Culture, Staphylococcus 87081; Identification CPT codes may vary based on method

0060126 Culture, Streptococcus (Group A) 87081; Identification CPT codes may vary based on method

0060131 Culture, Urine 87088; Identification CPT codes may vary based on method

0060159 Culture, Brucella 87081; Identification CPT codes may vary based on method

0060360 Culture, Corynebacterium diphtheriae 87081; Identification CPT codes may vary based on method

0060363 Culture, Vanco-Resistant Enterococcus 87081; Identification CPT codes may vary based on method

0070263 Leptin Quant by CIA 82397

0080108 Maternal Serum Screen AFP, hCG, Estriol (82105; 84702; 82677) or 81510*

*The 2014 AMA CPT manual contains the component CPT Codes and the new MAAA codes. Please direct any questions regarding CPT coding to the payer being billed.

0080269 Maternal Serum Screen AFP, hCG, EST, INH (82105; 84702;82677;86336) or 81511*

*The 2014 AMA CPT manual contains the component CPT Codes and the new MAAA codes. Please direct any questions regarding CPT coding to the payer being billed.

(3)

Page

3

of

7

0081064 Maternal Screening, INT-2 (82105; 84702;82677;86336) or 81511*

*The 2014 AMA CPT manual contains the component CPT Codes and the new MAAA codes. Please direct any questions regarding CPT coding to the payer being billed.

0081150 Maternal Serum, First Trimester (84702;84163) or 81508*

*The 2014 AMA CPT manual contains the component CPT Codes and the new MAAA codes. Please direct any questions regarding CPT coding to the payer being billed.

0081293 Maternal Screening, Sequential, Spec 1 (84702;84163) or 81508*

*The 2014 AMA CPT manual contains the component CPT Codes and the new MAAA codes. Please direct any questions regarding CPT coding to the payer being billed.

0081294 Maternal Screening, Sequential, Spec 2 (82105; 84702;82677;86336) or 81511*

*The 2014 AMA CPT manual contains the component CPT Codes and the new MAAA codes. Please direct any questions regarding CPT coding to the payer being billed.

0090050 Caffeine Level 80155

0090057 Gabapentin Level 80171

0090102 Doxepin and Metabolite, Serum or Plasma 80166

0090177 Lamotrigine 80175

0090213 Mycophenolic Acid 80180

0091541 Tiagabine, Serum or Plasma 80199

0092118 Everolimus 80169

0092209 CBFB-MYH11, inv(16) by RT-PCR 81401

0092660 Vascular Endothelial Growth Factor 82397

0095862 Lymphocyte Subset 6, with CD45RA/CD45RO 86355; 86357; 86359; 86360; 86356 x2

0095899 Lymphocyte Subset 7, Congenital Immun. 86355; 86357; 86359; 86360; 86356 x4

0097908 Zonisamide Quantitative 80203

0098627 Keppra (Levetiracetam) 80177

0098834 Oxcarbazepine Metabolite 80183

0098930 Clozapine 80159

2001932 KRAS Mutation Detection with BRAF Reflex 88381; 81275; 81403; If reflexed, add 81210 2001971 JPS (SMAD4) Sequencing and Del/Dup 81405; 81406

2001976 JPS (SMAD4) Deletion/Duplication 81405

2002005 Pancreatitis (CFTR, PRSS1, SPINK1) Seq 81223; 81404 x2

2002012 Pancreatitis, Idiopathic (SPINK1) Seq 81404

2002064 Chimerism Post-Transplant, Sorted Cells 81268; If sorted cells is performed, BMT will be billed additionally using CPT 88184; 88185

2002123 Allergen, Inhalants, Pro 28 86003 x27; 86005

(4)

Page

4

of

7

2002287 Chromosome Analysis Rule Out Mosaicism 88230; 88263; 88291

2002291 Chromosome Analysis Chorionic Villus 88269; 88235; 88291

2002297 Chromosome FISH Prenatal 88271 x5; 88275 x5; 88291

2002301 Microarray Family Study by FISH 88230; 88271; 88273; 88291

2002327 Mismatch Repair IHC with Reflex to BRAF 88342 x4; if reflexed, add 88381, 81210; if further reflexed, add 81479

2002357 JAK2 Exon 12 Mutation Analysis by PCR 81403

2002394 Alport Syndrome (COL4A5) Del/Dup 81407

2002398 Alport Syndrome (COL4A5) Seq and Del/Dup 81407; 81408

2002437 KIT Mutations in AML 81404

2002440 EGFR by Pyrosequencing 88381; 81235

2002498 BRAF Codon 600 Mutation Detection 88381; 81210

2002499 MLH1 Methylation by PCR 88381; 81479

2002674 Gastrointestinal Stromal Tumor Mutation 88381; 81404 x2

2002695 KIT Mutations, Melanoma 88381; 81404

2002871 PML-RARA Translocation, t(15;17) Quant 81315

2003123 NRAS Mutation Detection, Pyrosequencing 88381; 81404

2003243 SEPT9 Methylated DNA Detection 81401

2003401 PAH (BMPR2) Deletion/Duplication 81405

2003405 PAH (BMPR2) Seq and Del/Dup 81405; 81406

2003410 PAH (BMPR2) Sequencing 81406

2004115 PTEN by IHC 88360

2004203 PCD (SLC22A5) Seq and Del/Dup 81405; 81479

2004247 CEBPA Mutation Detection 81403

2004510 PIK3CA Mutation Detection 88381; 81479

2004516 Estrogen Receptor by IHC 88360

2004519 Ki-67, MIB-1 by IHC 88360

2004522 p53 by IHC 88360

2004525 Progesterone Receptor by IHC 88360

2004680 IL28B-Associated Variants, 2 SNPs 81400

2004745 FibroSURE 0001M

2004924 BCR-ABL1, T315I Mutation Detection, Quantitative 81401

2004927 CDKL5-Related Disorders (CDKL5) Del/Dup 81405

2004935 CDKL5-Related Disorders Seq and Del/Dup 81405; 81406

2005010 BCR-ABL1, Qualitative with Quant Reflex 81206; 81207; If reflexed, add 81206 or 81207 2005016 BCR-ABL1, Minor (p190), Quantitative 81207

2005017 BCR-ABL1, Major (p210), Quantitative 81206

2005018 Celiac HLA-DQA1*05, DQB1*02, DQB1*03:02 81376 x2

2005270 Mismatch Repair IHC with Reflex to MLH1 88342 x4; if reflexed, add 88381, 81479

(5)

Page

5

of

7

2005490 VWD Type 2M (VWF) Sequencing 81404

2005506 Trichomonas vaginalis by TMA 87661

2005545 MPL codon 515 Mutation Detection, Quant 81402

2005766 WT1 Mutation Detection 81479

2006050 Mito Disorders (108 Nuc. Genes) Seq. 81404 x9 (C10of2; COX6B1; CPT2; FXN; NDUFA1; NDUFS4; SCO2; SDHD; SLC25A5)

81405 x23 (ACADS; APTX; BCKDHA; BCSIL; COX10; COX15; DGUOK; FH; MPV17; NDUFS7; NDUFS8; NDUFV1; PDHB; PINK1; RRM2B; SCO1; SDHB; SDHC; SLC22A5; SLC25A20; SURF1; TK2; TYMP)

81406 x17 (ACADVL; ASS1; BCKHB; CPT1A; DBT; DLAT; DLD; HADHB; MCCC2; MFN2; NDUFS1; PC, PDHX, POLG, SDHA, SPG7, TAZ)

81407 (OPA1)

81479

2006054 Mito Disord Panel (mtDNA-108 Nuc Genes) 81403 x2 (MT-RNR1; MT-TS1)

81404 x11 (C10of2; COX6B1; CPT2; FXN; NDUFA1; NDUFS4; SCO2; SDHB (del); SDHC (del); SDHD; SLC25A5)

81405 x26 (ACADS; APTX; BCKDHA; BCSIL; COX10; COX15; DBT; DGUOK; FH; MPV17; NDUFS7; NDUFS8; NDUFV1; PDHB; PINK1; RRM2B; SCO1; SDHB; SDHC; SLC22A5; SLC25A20; SPG7; SURF1; TK2; TYMP; Mito del/dup)

81406 x19 (ACADVL; ASS1; BCKHB; CPT1A; DBT; DLAT; DLD; HADHA; HADHB; MCCC2; MFN2;NDUFS1; OPA1; PC; PDHX; POLG; SDHA; SPG7; TAZ)

81407 (OPA1)

81479 x2

2006061 mtDNA Genome and 108 Nuc. Genes Del/Dup 81404 x2 (SDHC, SLC25A20);

81405 x3 (DBT, Mito Genome DD, SPG7) 81406 (OPA1)

81479

2006193 B-Cell Clonality Screening (IgH and IgK) 81261; 81264

2006258 Sexually Transmitted Disease Panel 1 87491; 87591; 87661

2006301 Gabapentin Quantitative, Urine 80171

2006444 IDH1 and IDH2 Mutation Analysis, exon 4 81403 x2; FFPE tumor tissue, add 88381 2006516 BRAF V600E Mutation Detection, FNA 88381; 81210

2006540 Aortopathy Panel, Seq and Del/Dup 81405 x4 (ACTA2; SMAD4; TGFRB1; TGFRB2) 81406 x2 (CBS; SMAD4)

81408 x2 (FBN1; MYH11) 81479 x2

2006546 Aortopathy Del/Dup, 17 Genes 81405 (SMAD4)

81479

2006617 Aortopathy Sequencing, 17 Genes 81405 x3 (ACTA2; TGFRB1; TGFRB2) 81406 x2 (CBS; SMAD4)

81408 x2 (FBN1; MYH11) 81479

(6)

Page

6

of

7

2006621 Drug Detection Pan, TOF, Umbilical 80100 x2; 80101

2006872 Mito Disorders (mtDNA) Seq and DelDup 81403x2 (MT-RNR1; MT-TS1)

81405

81479 x2

2006878 Mito Disorders Nuclear Seq and DelDup 81404 x11 (C10of2, COX6B1, CPT2, FXN, NDUFA1, NDUFS4, SCO2, SDHC (del), SDHD, SLC25A20, SLC25A4)

81405 x25 (ACADS, APTX, BCKDHA, BCS1L, COX10, COX15, DBT, DGUOK, FH, MPV17, NDUFS7, NDUFS8, NDUFV1, PDHB, PINK1, RRM2B, SCO1, SDHB, SDHC, SLC22A5, SLC25A20, SPG7, SURF1, TK2, TYMP)

81406 x19(ACADVL, ASS1, BCKHB, CPT1A, DBT, DLAT, DLD, HADHA, HADHB, MCCC2, MFN2, NDUFS1, OPA1, PC, PDHX,

POLG, SDHA, SPG7, TAZ) 81407 (OPA1)

81479 x2

2006889 Cytology, FNA w/Rflx BRAF V600E, Request FNA-codes; if reflexed, add 88381; 81210

2007069 Citrullinemia, Type I (ASS1) Sequencing 81406

2007085 Retinitis Pigmentosa, Seq and Del/Dup 81404 x4 (CRX; PRPH2; RHO; RP) 81406 x3 (BEST1; CRB1; RPE65)

81408 x3 ( ABCA4; CEP290; USH2A)

81479 x2

2007091 Retinitis Pigmentosa Sequencing 81404 x4 (CRX; PRPH2; RHO; RP) 81406 x3 (BEST1; CRB1; RPE65)

81408 x3 (ABCA4; CEP290; USH2A)

81479 2007113 HPGL-PCC (SDHB,C,D) Deletion/Duplication 81404; 81479 2007117 HPGL-PCC (SDHC) Seq and DelDup 81404; 81405 2007132 BRAF V600E Detection Hairy Cell, Quant 81210

2007167 HPGL-PCC (SDHB,C,D) Seq and DelDup Panel 81404 x2; 81405 x2; 81479

2007329 ERBB2 (HER2) (4B5) by IHC 88360

2007332 ERBB2 (HER2) (HercepTest) by IHC 88360

2007361 Parasite Examination, Macroscopic 87169

2007380 Vascular Malformations Del/Dup, 10 Genes 81323

81405 x2 (ENG; SMAD4)

81479

2007384 Vasc Malformation Panel, Seq and Del/Dup 81321 (PTEN) 81323 (PTEN del)

81405 x2 (BMPR2; ENG) 81406 x2 (PMPR2; ENG)

81479 x2 2007390 Vascular Malformations Sequencing 81321 (PTEN)

81406 x2 (BMPR2; ENG)

81479 2007401 Succinylacetone, Quantitative, Urine 83921

2007880 Alpha Subunit, Pit. Glycoprotein Horm. 82397

(7)

Page

7

of

7

2007914 EPOR Mutation Detection by Sequencing 81479

2007991 Solid Tumor Mutation Panel by NGS 81210 (BRAF) 81235 (EGFR) 81275 (KRAS) 81310 (NPM1) 81402 (MPL)

81403 x6 (ABL1; CTNNB1; HRAS; IDH1; IDH2;KRAS) 81404 x6 ( FGFR2; FGFR3; KIT; NRAS; PDGFRA; RET) 81405 (TP53)

81479; 88381

2008116 Urine Culture, Invasive Collection 87088; Identification CPT codes may vary based on method

2008377 Peutz-Jeghers Syndrome (STK11) DelDup 81404

2008394 Peutz-Jeghers Syndrome (STK11) Seq 81405

2008398 Peutz-Jeghers Synd (STK11) Seq, DelDup 81404; 81405

2008409 T-Cell Clonality by NGS 81342

2008420 BCR-ABL1 Mutation Analysis by NGS 81403

2008426 Statin Sensitivity (SLCO1B1), 1 Variant 81400

2008476 Culture, Fluoroquinolone-Rstnt Org 87081; Identification CPT codes may vary based on method

2008803 Expanded Hearing Loss Panel, Seq/DelDup 81252 (GJB2) 81254 (GJB6) 81404 x2 (CLRN1; USH1G) 81405 (DFNB59) 81406 x2 (PCDH15; SLC26A4) 81407 x3 (MYO7A; PCDH15; USH1C) 81408 x2 (CDH23; USH2A) 81479x2 2008808 Expanded Hearing Loss Panel Del/Dup 81406 (PCDH15)

81479 2008831 Metabolic Storage Disorders Sequencing 81250 (G6PC)

81251 (GBA) 81290 (MCOLN1) 81330 (SMPD1)

81404 (NPC2)

81405 x3 (ARSA; GLA; IDS)

81406 x5 (GAA; GALC; IDUA; NPC1; PYGM; SLC37A4)

81407 (AGL)

81479

References

Related documents

Level Summon Rank Special Rank 1st Soldier — 2nd Protector Elite 3rd Protector Elite 4th Guardian Elite 5th Guardian Paragon 6th Noble Paragon 7th Champion Paragon.. The death of

The overall objective of this research is to study the effectiveness of Electronic Quality Management System (e-QMS) implementation strategies in a manufacturing company.

2012 Code (Deleted as of   January 1, 2013)   2013 New Replacement Code  

Risk Reporting ensures that the team, sponsor, and other stakeholders are aware of the status of project risks and the plans to manage them.

Climate change to the global public group at greenwich associates, and a member of your investment management group companies make principal and other funds.. Leads sales at the

The XTNDConnect Server communication layer handles the connectivity between the devices and the sync engine, as well as between the sync engine and database servers.. Although

Customers with accounts created prior to this policy will not be requested to complete the Credit Application and Agreement as long as their account is not over 90 days past due..

The height of all sectoral antennas are matched with the planned engineering parameter Plan: Sector 0: Sector 1: Sector 2: Actual: Sector 0: Sector 1: Sector 2: □Pass